Healthcare & Life Sciences News and Articles

Industry News External News

First lady visits cultural theme park, biotech firm in Indonesia - The Korea Herald

news.google.com · 07 Sep 2023

Google News – EMA (biotech/pharma) External News

Spanish drugmaker Serra Pamies suffers manufacturing clampdown by EMA - Fierce Pharma

news.google.com · 22 Aug 2023

Google News – EMA (biotech/pharma) External News

EMA backs SV95C as digital primary endpoint for DMD trials - pharmaphorum

news.google.com · 09 Aug 2023

Google_site External News

Biotech startup DotBio raises US$5.6 million pre-Series A round - The Business Times

news.google.com · 07 Aug 2023

Industry News External News

Kyoto University's VC fund to invest $140m in AI and biotech - Nikkei Asia

news.google.com · 05 Aug 2023

Google News – EMA (biotech/pharma) External News

Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe - Fierce Pharma

news.google.com · 21 Jul 2023

Google News – EMA (biotech/pharma) External News

Paper outlines EMA's early thoughts on AI - The Pharmaletter

news.google.com · 19 Jul 2023

Google News – EMA (biotech/pharma) External News

Moderna submits EMA filing for updated COVID-19 jab - The Pharmaletter

news.google.com · 03 Jul 2023

Google News – EMA (biotech/pharma) External News

Batch of EMA/CHMP recommendations from June 2023 meeting - The Pharmaletter

news.google.com · 23 Jun 2023

Google News – Cardiology External News

Six companies that have made their name in the cardiovascular space - Labiotech.eu

news.google.com · 08 Jun 2023

Google News – Cardiology External News

Bitterroot Bio, a new biotech company launched by physicians and industry veterans, raises $145M - Cardiovascular Business

news.google.com · 08 Jun 2023

Google News – EMA (biotech/pharma) External News

Amylyx warns EMA unlikely to approve ALS drug AMX0035 - The Pharmaletter

news.google.com · 31 May 2023

Google News – EMA (biotech/pharma) External News

Six novel meds recommended for approval by EMA/CHMP - The Pharmaletter

news.google.com · 28 Apr 2023

Google News – EMA (biotech/pharma) External News

French biotech pulls EMA application for eye disease gene therapy - BioPharma Dive

news.google.com · 21 Apr 2023

Google News – Cardiology External News

Merck's cardiovascular future takes shape as sotatercept overachieves, PCSK9 inhibitor passes phase 2 - Fierce Biotech

news.google.com · 06 Mar 2023

News & Articles

The 90-Day Capability Reset for Healthcare Employers

The Decision Architecture Skill Clinical Research Teams Need

Beta Bionics’ insulin patch pump gets FDA nod

HR must set boundaries as it embraces AI notetakers, experts caution

Staff slept while patient killed at NHS mental health unit

Hong Kong parents urged to vaccinate young children amid rising summer flu cases

PEN-Plus operations manual

Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions

Responsible spending starts with timely access, informed choices and more connected care

The future of talent sourcing is more than clicks

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Lakeland Community Hospital receives grant to expand rural healthcare access - alreporter.com

Stryker stock falls on slower peripheral vascular, hip sales

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

First lady visits cultural theme park, biotech firm in Indonesia - The Korea Herald

Spanish drugmaker Serra Pamies suffers manufacturing clampdown by EMA - Fierce Pharma

EMA backs SV95C as digital primary endpoint for DMD trials - pharmaphorum

Biotech startup DotBio raises US$5.6 million pre-Series A round - The Business Times

Kyoto University's VC fund to invest $140m in AI and biotech - Nikkei Asia

Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe - Fierce Pharma

Paper outlines EMA's early thoughts on AI - The Pharmaletter

Moderna submits EMA filing for updated COVID-19 jab - The Pharmaletter

Batch of EMA/CHMP recommendations from June 2023 meeting - The Pharmaletter

Six companies that have made their name in the cardiovascular space - Labiotech.eu

Bitterroot Bio, a new biotech company launched by physicians and industry veterans, raises $145M - Cardiovascular Business

Amylyx warns EMA unlikely to approve ALS drug AMX0035 - The Pharmaletter

Six novel meds recommended for approval by EMA/CHMP - The Pharmaletter

French biotech pulls EMA application for eye disease gene therapy - BioPharma Dive

Merck's cardiovascular future takes shape as sotatercept overachieves, PCSK9 inhibitor passes phase 2 - Fierce Biotech